Case Note & Summary
The case involves an appeal by the Employees State Insurance Corporation (ESIC) against an order of the ESI Court, Nagpur, which set aside a communication by ESIC informing the respondent hospital that it falls within the coverage of the ESI Act. The respondent, The Central India Institute of Medical Sciences, is a scientific research institute and charitable trust running a hospital with four departments, including a pathology and biochemistry laboratory. The ESIC had sought to cover the hospital under the ESI Act on the ground that the pathological laboratory constitutes a 'factory' under Section 2(12)(a) of the Act. The respondent challenged this before the ESI Court, which allowed the application. The High Court framed the substantial question of law: whether the respondent hospital, having a pathological laboratory that caters to outsiders as well as indoor patients, is a factory under Section 2(12)(a) of the ESI Act. The court analyzed the definition of 'factory' under the ESI Act, which adopts the definition under the Factories Act, 1948, requiring a 'manufacturing process' as defined in Section 2(k) of the Factories Act. The court noted that the pathological laboratory conducts diagnostic tests such as blood, urine, and other pathological examinations, which do not involve any manufacturing process. The court held that diagnostic tests do not result in the production of any article or substance; they merely aid in diagnosis. Therefore, the hospital is not a factory, and the ESI Court's order was correct. The appeal was dismissed.
Headnote
A) ESI Act - Definition of Factory - Pathological Laboratory - The question was whether a hospital with a pathological laboratory that serves both indoor and outdoor patients falls within the definition of 'factory' under Section 2(12)(a) of the Employees State Insurance Act, 1948. The court held that the pathological laboratory does not carry out a 'manufacturing process' as defined under Section 2(k) of the Factories Act, 1948, and therefore the hospital is not a factory. The ESI Court's order setting aside the coverage was upheld. (Paras 2-10) B) ESI Act - Manufacturing Process - Diagnostic Tests - Diagnostic tests conducted in a pathological laboratory, such as blood tests, urine tests, etc., do not amount to a 'manufacturing process' as they do not involve any alteration or transformation of substances into a new product. The court relied on the principle that the definition of 'manufacturing process' requires some kind of production or alteration, which is absent in diagnostic activities. (Paras 8-10)
Issue of Consideration
Whether a hospital having a pathological laboratory that caters to outsiders as well as indoor patients is a 'factory' within the meaning of Section 2(12)(a) of the Employees State Insurance Act, 1948.
Final Decision
The High Court dismissed the appeal, upholding the ESI Court's order that the respondent hospital is not a factory under Section 2(12)(a) of the ESI Act.
Law Points
- Definition of factory under ESI Act
- Manufacturing process
- Pathological laboratory not a factory
- Section 2(12)(a) ESI Act
- Section 2(k) Factories Act
